Director, PRESIDENT AND CEO · Immuneering Corp · Class A Common Stock
Side
BUY
Value
$11K
Shares
2,400
Price
$4.56
Executed
Jun 23, 2026
Disclosed
Jun 24, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jun 23 executedJun 24, 2026 disclosed
IMRX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Zeskind Benjamin J. filed this Form 4 reporting a open-market purchase of IMRX on Jun 23, 2026. It became public on Jun 24, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, PRESIDENT AND CEO
Zeskind Benjamin J.cik:0001870062
Issuer
Immuneering Corpcik:0001790340
Revision history · 0
No field has changed since this record was first ingested.
